The Inspire SleepSync platform is a connected patient management system designed to improve the Inspire therapy experience for patients and providers. Consisting of the bluetooth-enabled Inspire™remote, the Inspire®app, and the SleepSync web portal, the Inspire SleepSync platform enables wireless ...
Inspire therapy may be a treatment option for your obstructive sleep apnea patients who struggle with CPAP.
Inspire Medical Systems specializes in innovative treatments for obstructive sleep apnea within the medical device industry. The company offers a mask-free, implantable system that provides an alternative to CPAP therapy for individuals who have not found success with traditional treatments. Inspire therapy...
Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, t...
This session focused on treatments and clinical trials in obstructive sleep apnea, immune system dysregulation, obesity, and psychiatric disorders, among others. Research Advances in Obstructive Sleep Apnea Treatment for People with DS People with DS have a high prevalence of obstructive sleep apnea (...
(NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase (“ASR”) ...
Minneapolis, MN-based Inspire Medical is a medical technology company focused on the development and commercialization of innovative, minimally-invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the first and only FDA-approved neurostimulation technology th...
Financial Performance:Inspire Medical Systems reported a 30% increase in revenue for Q2 2024, leading to an increase in their full-year 2024 revenue guidance. Inspire Medical Systems Inc, maker of Inspire therapy for the treatment of obstructive sleep apnea, reported its second-qu...
Several systems for electrical stimulation of the genioglossus muscle to improve pharyngeal patency in obstructive sleep apnea exist. In this first part of this chapter, the Inspire system is discussed, in the second part the Aura6000 (Liva Nova) system, in the third part the Genio system (...
(NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced certain preliminary, unaudited results for the fourth quarter and full yea...